Cytokinetics, Incorporated · NASDAQ:CYTK
Parshall B Lynne sold 5,000 Cytokinetics, Incorporated shares (Form 4)
Traded Nov 9, 2026 · Filed Nov 12, 2026
On Nov 9, 2026, Parshall B Lynne (Director) sold 5,000 Cytokinetics, Incorporated shares at an average US$54.73 for US$274K under a trading plan, leaving 5,784 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$54.73 average (US$54.17 to US$55.26)
- Value
- US$274K
- Holding after
- 5,784 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock | Sale | 2,445 | US$54.17 | 8,339 | Direct |
| Nov 9, 2026 | Common Stock | Sale | 2,555 | US$55.26 | 5,784 | Direct |
Source
Download original · View original at SEC
Related
- Cytokinetics, Incorporated
- Parshall B Lynne
- Cytokinetics, Incorporated shareholders
- Form 4 · Parshall B Lynne · Sep 1, 2026
- Form 4 · Parshall B Lynne · Jun 1, 2026
- Form 4 · Parshall B Lynne · May 27, 2026
- Form 4 · Malik Fady Ibraham · Nov 18, 2026
- Form 4 · Hessekiel Jeffrey · Nov 18, 2026
- Form 4 · Blum Robert I · Nov 18, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 16, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026